Home » Authors » Cormac Sheridan

Cormac Sheridan

Articles

ARTICLES

7TM Pharma Raising EUR19M To Fuel 7TM Receptor Work

April 5, 2006

By Cormac Sheridan

Speedel Raises CHF79.7M In Sale Of Treasury Shares

March 29, 2006

By Cormac Sheridan

PanGenetics Brings In EUR13M For Antibody Development

March 29, 2006

By Cormac Sheridan

Pharming Acquiring DNAge: Milestones, EUR15M In Shares

March 29, 2006

By Cormac Sheridan

Speedel Raises CHF79.7M In Sale Of Treasury Shares

March 29, 2006

By Cormac Sheridan

PanGenetics Brings In EUR13M For Antibody Development

March 29, 2006

By Cormac Sheridan

Pharming Acquiring DNAge: Milestones, EUR15M In Shares

March 29, 2006

By Cormac Sheridan

Santaris Bringing In EUR40M For Developing LNA Drugs

March 22, 2006

By Cormac Sheridan

Santaris Bringing In EUR40M For Developing LNA Drugs

March 22, 2006

By Cormac Sheridan

Egalet Gets $27.6M For Trials Of Controlled-Release Drugs

March 15, 2006

By Cormac Sheridan

View All Articles by Cormac Sheridan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...